The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Relatively Poor Outcome after Treatment of Clostridium difficile Colitis with Metronidazole
Abstract
BACKGROUND: Clostridium difficile is a frequent cause of serious nosocomial infection. Earlier reports have suggested that treatment with metronidazole cured nearly 90% of patients, with only a modest rate of recurrence of infection. In recent years, the rate of response to treatment with this drug has appeared to be much lower. METHODS: We undertook a prospective, observational study of 207 patients who were treated with metronidazole for C. difficile colitis. RESULTS: A total of 103 patients (50%) were cured by the initial course of therapy and had no recurrence of disease. Forty-six patients (22%) continued to have symptoms of colitis for > or = 10 days despite treatment, and 58 (28%) responded initially but had a recurrence within the ensuing 90 days. The mortality rate among patients who developed C. difficile colitis was 27%, and it was higher among patients who did not respond fully to an initial course of therapy, compared with those who did (33% vs. 21%; P < .05). CONCLUSIONS: Because of the relatively poor response to therapy, additional approaches to prevention and/or treatment of C. difficile colitis appear to be warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibiotic-Associated Diarrhea
Bartlett, J. G. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp011603 · Cited by 1,197
Pepin, J. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1041104 · Cited by 1,128
Asymptomatic Carriage of Clostridium difficile and Serum Levels of IgG Antibody against Toxin A
Kyne, L., Warny, M., Qamar, A., & Kelly, C. P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420604 · Cited by 935
Kyne, L., Warny, M., Qamar, A., & Kelly, C. P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03592-3 · Cited by 804
Teasley, D., Olson, M., Gebhard, R., Gerding, D., Peterson, L., Schwartz, M., & Lee, J. (1983) · The Lancet · doi:10.1016/s0140-6736(83)91036-x · Cited by 785
The American Journal of Gastroenterology
(2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(03)01892-6 · Cited by 649
Safdar, N., & Maki, D. G. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-11-200206040-00013 · Cited by 556
Clostridium difficile–Associated Diarrhea
Johnson, S., & Gerding, D. N. (1998) · Clinical Infectious Diseases · doi:10.1086/520276 · Cited by 441
Clostridium difficile-associated diarrhea in adults
Poutanen, S. M. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1031189 · Cited by 410
Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea
Shim, J. K., Johnson, S., Samore, M. H., Bliss, D. Z., & Gerding, D. N. (1998) · The Lancet · doi:10.1016/s0140-6736(97)08062-8 · Cited by 391
Fekety, R., McFarland, L. V., Surawicz, C. M., Greenberg, R. N., Elmer, G. W., & Mulligan, M. E. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.3.324 · Cited by 376
Olson, M. M., Shanholtzer, C. J., Lee, J. T., & Gerding, D. N. (1994) · Infection Control & Hospital Epidemiology · doi:10.1086/646934 · Cited by 339
Clostridium difficile–Associated Diarrhea: A Review
Mylonakis, E., Ryan, E. T., & Calderwood, S. B. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.4.525 · Cited by 339
Gaynes, R., Rimland, D., Killum, E., Ken Lowery, H., Johnson II, T. M., Killgore, G., & Tenover, F. C. (2004) · Clinical Infectious Diseases · doi:10.1086/381551 · Cited by 251
Underlying Disease Severity as a Major Risk Factor for Nosocomial Clostridium difficile Diarrhea
Kyne, L., Sougioultzis, S., McFarland, L. V., & Kelly, C. P. (2002) · Infection Control & Hospital Epidemiology · doi:10.1086/501989 · Cited by 242
Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection
Warny, M., Vaerman, J. P., Avesani, V, & Delmée, M. (1994) · Infection and Immunity · doi:10.1128/iai.62.2.384-389.1994 · Cited by 230
The effect of probiotics on clostridium difficile diarrhea
POCHAPIN, M. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00809-6 · Cited by 227
Secular Trends in Hospital‐Acquired Clostridium difficile Disease in the United States, 1987–2001
Archibald, L. K., Banerjee, S. N., & Jarvis, W. R. (2004) · The Journal of Infectious Diseases · doi:10.1086/383045 · Cited by 206
Fluoroquinolone Use and Clostridium difficile–associated Diarrhea
McCusker, M. E., Harris, A. D., Perencevich, E., & Roghmann, M.-C. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0906.020385 · Cited by 200
Gerding, D. N. (2004) · Clinical Infectious Diseases · doi:10.1086/382084 · Cited by 175
Norén, T., Åkerlund, T., Bäck, E., Sjöberg, L., Persson, I., Alriksson, I., & Burman, L. G. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.8.3635-3643.2004 · Cited by 160
Kink, J. A., & Williams, J. A. (1998) · Infection and Immunity · doi:10.1128/iai.66.5.2018-2025.1998 · Cited by 159
Clostridium difficile Vaccine and Serum Immunoglobulin G Antibody Response to Toxin A
Aboudola, S., Kotloff, K. L., Kyne, L., Warny, M., Kelly, E. C., Sougioultzis, S., Giannasca, P. J., Monath, T. P. C., & Kelly, C. P. (2003) · Infection and Immunity · doi:10.1128/iai.71.3.1608-1610.2003 · Cited by 138
Nair, S. P., Yadav, D. K., Corpuz, M. O., & Pitchumoni, C. S. (1998) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1998.00541.x · Cited by 130
Active and passive immunization against Clostridium difficile diarrhea and colitis
Giannasca, P. J., & Warny, M. (2003) · Vaccine · doi:10.1016/j.vaccine.2003.11.030 · Cited by 120
Clostridium difficile infection in patients with unexplained leukocytosis
Wanahita, A., Goldsmith, E. A., Marino, B., & Musher, D. M. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(03)00420-0 · Cited by 112
Self-citationWilcox, M. H. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh285 · Cited by 100
Treatment of Clostridium difficile colitis and diarrhea with vancomycin
Silva, J., Batts, D. H., Fekety, R., Plouffe, J. F., Rifkin, G. D., & Baird, I. M. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90369-7 · Cited by 78
Wilcox, M. H., Fawley, W. N., Freeman, J., & Brayson, J. C. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.4.551 · Cited by 49
Cited by
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
Cohen, S. H., Gerding, D. N., Johnson, S., Kelly, C. P., Loo, V. G., McDonald, L. C., Pepin, J., & Wilcox, M. H. (2010) · Infection Control & Hospital Epidemiology · doi:10.1086/651706 · Cited by 2,942
McDonald, L. C., Gerding, D. N., Johnson, S., Bakken, J. S., Carroll, K. C., Coffin, S. E., Dubberke, E. R., Garey, K. W., Gould, C. V., Kelly, C., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix1085 · Cited by 2,690
Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections
Surawicz, C. M., Brandt, L. J., Binion, D. G., Ananthakrishnan, A. N., Curry, S. R., Gilligan, P. H., McFarland, L. V., Mellow, M., & Zuckerbraun, B. S. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.4 · Cited by 1,645
Fidaxomicin versus Vancomycin for Clostridium difficile Infection
Louie, T. J., Miller, M. A., Mullane, K. M., Weiss, K., Lentnek, A., Golan, Y., Gorbach, S., Sears, P., & Shue, Y.-K. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa0910812 · Cited by 1,585
Metadata
- Authors
- Musher, D. M., Aslam, S., Logan, N., Nallacheru, S., Bhaila, I., Borchert, F., & Hamill, R. J.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-06-01
- Volume
- 40
- Issue
- 11
- Pages
- 1586-1590
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2109743785
- Cited by
- 504
- References
- 30
- FWCI
- 28.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.